1203O FOLFOX plus nivolumab and ipilimumab versus FOLFOX induction followed by nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Results from the randomized phase II Moonlight trial of the AIO
暂无分享,去创建一个
V. Heinemann | S. Al-Batran | T. Gaiser | D. Pink | E. Goekkurt | T. Ettrich | T. Dechow | O. Waidmann | S. Lorenzen | P. Thuss-Patience | C. Pauligk | J. Riera Knorrenschild | G. Folprecht | K. Luley | J. Moulin | T. Götze | U. Lindig | C. Bolling | S. Angermeier | S. Junge